Veru Inc. Reports Q2 2025 Financials

Ticker: VERU · Form: 10-Q · Filed: May 8, 2025 · CIK: 863894

Sentiment: neutral

Topics: 10-Q, financials, pharmaceuticals

TL;DR

Veru Inc. Q2 2025: Assets up slightly, still reporting losses. Keep an eye on cash burn.

AI Summary

Veru Inc. filed its 10-Q for the period ending March 31, 2025, reporting a net loss for the quarter. The company's total assets were $148.8 million as of March 31, 2025, compared to $146.6 million as of September 30, 2024. Total liabilities stood at $2.2 million as of March 31, 2025.

Why It Matters

This filing provides insight into Veru Inc.'s financial health and operational performance during the second quarter of fiscal year 2025, which is crucial for investors assessing the company's trajectory.

Risk Assessment

Risk Level: medium — The company is in the pharmaceutical sector and has reported net losses, indicating potential financial instability and R&D risks.

Key Numbers

Key Players & Entities

FAQ

What was Veru Inc.'s net loss for the three months ended March 31, 2025?

The filing indicates a net loss of $0.01 per share (diluted) for the three months ended March 31, 2025.

How have Veru Inc.'s total assets changed from September 30, 2024, to March 31, 2025?

Total assets increased from $146,583,920 as of September 30, 2024, to $148,767,624 as of March 31, 2025.

What were Veru Inc.'s total liabilities as of March 31, 2025?

Total liabilities for Veru Inc. were $2,183,704 as of March 31, 2025.

What is Veru Inc.'s fiscal year end?

Veru Inc.'s fiscal year ends on September 30.

What was the filing date for this 10-Q report?

This 10-Q report was filed on May 8, 2025.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding VERU INC. (VERU).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing